Keyword: Gleevec

Colombia plots 45% price cut on Novartis' Gleevec

A tense, months-long pricing standoff escalated late last week as Colombia announced plans to unilaterally move forward with a “public interest” measure that’ll cut the price of Novartis’ chronic myeloid leukemia med Gleevec there by about 45%.